- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00380926
Fish Oil and Asthma in House Dust Mite Allergy
Anti-Inflammatory Effect of Polyunsaturated Fatty Acids in Allergic Asthma After Allergen Challenge
Study Overview
Status
Intervention / Treatment
Detailed Description
Most asthmatics suffer from mild disease and non pharmacologic intervention would be beneficial for the majority of these subjects. We investigated the anti-inflammatory potential of polyunsaturated fatty acids (PUFA) in allergic asthma.
In our parallel, double-blinded study, 23 patients allergic to house dust mite were randomly assigned to dietary supplementation with a PUFA enriched fat blend or placebo for five weeks. The verum contained eicosapentaenoic acid (EPA) 450 mg/day, docosahexaenoic acid 180 mg/day, stearidonic acid 60mg/day, and gamma-linolenic acid 60 mg/day; the placebo consisted of mainly unsaturated and monosaturated fatty acids. After three weeks, the patients were challenged with low doses of inhalative house dust mite allergen for two weeks.
Following parameters were determined during low-dose allergen exposure in both groups: exhaled NO (eNO) as a marker of bronchial inflammation, clinical symptoms, FEV1, beta-agonist usage, and bronchial hyperreactivity, sputum eosinophils and sulfoleucotrienes. Compliance with the study protocol was controlled by the determination of PUFAs in plasma and erythrocytes.
Study Type
Enrollment
Phase
- Phase 2
- Phase 3
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- allergic sensitization to house dust mite as proven by skin test and specific IgE
- normal lung function, episodic asthma
Exclusion Criteria:
- history of hypersensitization towards fish oil, chronic illness, pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
lung function, symptom score,exhalative nitric oxide, metacholine testing
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
sulfoleucotriens, eosinophilic cationic protein, sputum eosinophils, safety lab parameters (clinical chemistry, hematology, hemostasis)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Prof. Stefan Zielen, M.D., Goethe University, Dpt of Pulmonology/Allergy
Publications and helpful links
General Publications
- Horrobin DF. Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med Hypotheses. 1987; 22(4):421-8. Stephensen CB. Fish oil and inflammatory disease: is asthma the next target for n-3 fatty acid supplements? Nutr Rev 2004; 62:486-489 Woods RK, Thien FC, Abramson MJ. Dietary marine fatty acids (fish oil) for asthma in adults and children. Cochrane Database Syst Rev2002; CD001283 Dry J, Vincent D. Effect of a fish oil diet on asthma: results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991; 95:156-157 Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H. Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allergy 1989; 62:534-537 Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006; 129:39-49
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZAFES-2004-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allergic Asthma
-
Henan University of Traditional Chinese MedicineNot yet recruiting
-
Longbio PharmaRecruitingAllergic AsthmaChina
-
Daewon Pharmaceutical Co., Ltd.RecruitingPerennial Allergic Rhinitis Accompanied by AsthmaSouth Korea
-
University of MelbourneMelbourne Health; The Alfred; Queensland University of Technology; Eastern Health; Monash Medical Centre and other collaboratorsRecruitingSeasonal Allergic Rhinitis | Allergic Asthma | Grass Pollen Allergy | Asthma Acute | Thunderstorm Asthma | Asthma Exacerbation Due to ThunderstormAustralia
-
University of ZurichUniversity of AarhusCompletedAllergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Allergic Asthma | Rhinitis; Allergic, With AsthmaSwitzerland
-
Children's Mercy Hospital Kansas CityCompletedAsthma | Allergic Asthma | Non-allergic AsthmaUnited States
-
AJU Pharm Co., Ltd.Not yet recruitingPerennial Allergic Rhinitis | Bronchial AsthmaSouth Korea
-
Allergopharma GmbH & Co. KGNot yet recruitingAllergic Rhinitis Due to House Dust Mite | Allergic Asthma Due to Dermatophagoides Farinae | Allergic Asthma Due to Dermatophagoides Pteronyssinus | Allergic Conjunctivitis Due to Dermatophagoides Farinae | Allergic Conjunctivitis Due to Dermatophagoides Pteronyssinus
-
The Cleveland ClinicEnrolling by invitation
-
Dr. Anne EllisActive, not recruitingAsthma With Allergic RhinitisCanada
Clinical Trials on polyunsatturated fatty acids (fish oil)
-
Landspitali University HospitalMatis ohf.; Lipid Pharmaceuticals ehf.Not yet recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedProteomics | Lipoprotein Metabolism | PCSK9United States
-
Evandro Chagas Institute of Clinical ResearchAndrea Silvestre de Sousa, MD PhD; Pedro Emmanuel Alvarenga Americano do Brasil... and other collaboratorsCompletedChagas CardiomyopathyBrazil
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH)CompletedDepression | Depressive Symptoms | MoodUnited States
-
Icahn School of Medicine at Mount SinaiNational Center for Complementary and Integrative Health (NCCIH); National...Completed
-
Shanghai Jiao Tong University School of MedicineCompletedType 2 Diabetes Mellitus | HypertriglyceridemiaChina
-
St. Mary's University, TwickenhamNot yet recruitingFocus on Omega 3 Index on Recovery
-
Milton S. Hershey Medical CenterTerminated
-
Icahn School of Medicine at Mount SinaiNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Aalborg University HospitalCompletedPostmenopause | PremenopauseDenmark